We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$63.6M
Cap. Flow
-$14.6M
Cap. Flow %
-1.4%
Top 10 Hldgs %
44.54%
Holding
900
New
268
Increased
133
Reduced
141
Closed
310

Top Buys

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$64.9M
2
ARKK icon
ARK Innovation ETF
ARKK
+$54.7M
3
FULC icon
Fulcrum Therapeutics
FULC
+$48.9M
4
RIVN icon
Rivian
RIVN
+$32.4M
5
STOK icon
Stoke Therapeutics
STOK
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 39.85%
2 Financials 15.44%
3 Materials 6.54%
4 Consumer Discretionary 6.02%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEL.U
151
DELISTED
Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
WEL.U
$549K 0.05%
+54,300
New +$547K
AFACW
152
DELISTED
Arena Fortify Acquisition Corp. Warrant
AFACW
$545K 0.05%
+545,000
New +$213K
ASZ.WS
153
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$544K 0.05%
971,800
+921,800
+1,844% +$577K
BSGA
154
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
$537K 0.05%
53,401
-12,099
-18% -$121K
CERN
155
DELISTED
Cerner Corp
CERN
$535K 0.05%
+5,720
New +$529K
CRESW
156
DELISTED
Cresud SACIF y A. Warrant
CRESW
$514K 0.05%
+979,450
New +$278K
AGIO icon
157
PUT
Agios Pharmaceuticals
AGIO
$1.98B
$500K 0.05%
30,000
+10,000
+50% +$306K
NIR
158
DELISTED
Near Intelligence, Inc. Common Stock
NIR
$497K 0.05%
50,000
GSAQ
159
DELISTED
Global Synergy Acquisition Corp. Class A Ordinary Shares
GSAQ
$497K 0.05%
50,000
ALGN icon
160
Align Technology
ALGN
$12.4B
$493K 0.05%
1,131
+370
+49% +$180K
IONS icon
161
Ionis Pharmaceuticals
IONS
$9.36B
$491K 0.05%
13,257
+5,527
+72% +$181K
ZLSWU
162
DELISTED
Zalatoris II Acquisition Corp Unit
ZLSWU
$491K 0.05%
+50,000
New +$490K
WST icon
163
West Pharmaceutical
WST
$24.6B
$487K 0.05%
1,186
+387
+48% +$152K
HMCOW
164
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$478K 0.05%
1,494,407
+434,382
+41% +$227K
ZBH icon
165
Zimmer Biomet
ZBH
$18.7B
$477K 0.05%
3,727
-4,832
-56% -$582K
SNTI icon
166
Senti Biosciences Holdings
SNTI
$11.2M
$466K 0.04%
4,720
-18,350
-80% -$1.81M
STE icon
167
Steris
STE
$23.4B
$466K 0.04%
+1,927
New +$447K
BLNK icon
168
PUT
Blink Charging
BLNK
$85.5M
$464K 0.04%
+55,000
New +$1.29M
FOA icon
169
Finance of America Companies
FOA
$196M
$447K 0.04%
14,700
-57,122
-80% -$1.99M
BYND icon
170
PUT
Beyond Meat
BYND
$213M
$444K 0.04%
+151,600
New +$8.33M
IBM icon
171
IBM
IBM
$226B
$442K 0.04%
3,400
-20,196
-86% -$2.63M
SVFA
172
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$439K 0.04%
44,749
-44,607
-50% -$438K
BOAC.WS
173
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$434K 0.04%
1,289,683
+1,087,832
+539% +$496K
FOA.WS
174
DELISTED
Finance of America Companies Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
FOA.WS
$420K 0.04%
1,069,604
+710,719
+198% +$309K
TTWO icon
175
PUT
Take-Two Interactive
TTWO
$47.2B
$416K 0.04%
+61,200
New +$9.79M

Similar funds

Cowen and Company's Q1 2022 Portfolio in Review

As of Q1 2022, Cowen and Company held 900 positions worth $1.04B, down 5.8% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cowen and Company's Q1 2022 filing shows 268 new, 133 increased, 141 reduced and 310 closed positions. Its largest new stake was Sylvamo: 1,955,000 shares worth $65.1M. The largest sale was Invesco QQQ Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 26% a quarter earlier, followed by Financials and Materials.

  • Cowen and Company's largest Q1 2022 buy was Sylvamo: 1,955,000 shares worth $65.1M.
  • Cowen and Company added most to ARK Innovation ETF in Q1 2022, an estimated $54.7M increase.
  • Cowen and Company's biggest Q1 2022 reduction was Invesco QQQ Trust, cutting an estimated $143M.
  • Cowen and Company fully exited Churchill Capital Corp VI in Q1 2022, selling an estimated $34.2M.
  • Cowen and Company's ten largest holdings make up 45% of its $1.04B portfolio in Q1 2022.
  • Cowen and Company opened 268 new positions and closed 310 in Q1 2022.
  • Cowen and Company's portfolio value fell 5.8% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.